A smartphone symptom-management app for children early after cancer treatment and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will assign paediatric cancer survivors and their primary caregivers to either immediate access to a symptom-management mobile app with 12 weeks of personalized nurse support or to a wait-list control. Eligible children are aged 9–16, have completed active cancer treatment within the past two years, can read Chinese, and have a smartphone or tablet; their primary caregivers must also be Chinese-speaking and willing to use the app. Key outcomes measured at baseline and three months include children's physical function, anxiety, depressive symptoms, fatigue, peer relationships, and pain interference, and caregiver quality of life. The intervention combines app-based symptom tracking, tailored self-management content, and interactive nurse support, while the control group receives the app after the waiting period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Chinese paediatric cancer survivors will be included if they

* are aged 9 to 16 years,
* are able to read Chinese and communicate in Chinese,
* have completed active cancer treatment (within the previous 2 years), as early symptom management support is crucial to reduce the symptom burden in survivors and their caregivers throughout their survivorship, and
* have a smartphone or tablet and are willing to install the mHealth app.

The primary caregiver of the paediatric cancer survivors (either the mother or father)

* are able to read Chinese and communicate in Chinese, and
* have a smartphone or tablet and are willing to install the mHealth app with their children surviving cancer.

Exclusion Criteria:

Chinese paediatric cancer survivors will be excluded if they

* have cognitive impairments or psychiatric illnesses
* are currently participating in other symptom management studies, or
* have evidence of secondary malignancy or recurrence

The primary caregivers of the paediatric cancer survivors (either the mother or father) will be excluded if they have cognitive impairments or psychiatric illnesses.

Where it's running

• The Chinese University of Hong Kong
  Hong Kong, Hong Kong Recruiting
• The Chinese University of Hong Kong
  Hong Kong, Hong Kong Not yet recruiting

Study contacts

• Principal investigator: Ankie Tan Cheung, PhD — Chinese University of Hong Kong
• Study coordinator: Ankie Tan Cheung, PhD
• Email: ankiecheung@cuhk.edu.hk
• Phone: 852 3943 0515

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive training with real-time brain feedback for childhood medulloblastoma survivors

  This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07830134

• Hematologic cancer survivors after stem cell transplant try a personalized care plan

  This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07579065

• Support program to improve quality of life for Chinese cancer patients and survivors

  This program will try different mixes of education, counseling, and peer support to see if they help Mandarin-speaking adults with cancer or who have finished treatment feel better.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07454330

• On-Trac: Online training to manage anxiety after cancer

  This program will try an online CBT- and ACT-based education plus brief coaching to help adult cancer survivors manage ongoing anxiety.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07305740

• Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction

  This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.

  Recruiting University of Virginia · Charlottesville, Virginia · NCT07264036

• LiveWell: a tailored DBT skills program for people living with metastatic lung cancer

  This pilot randomized trial tests a telehealth DBT skills program called LiveWell for adults with metastatic non-small cell lung cancer and distress to see if it reduces distress and improves well-being compared to usual care.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07177846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.